Volume 76, Pages S3-S11 (December 2009)

Slides:



Advertisements
Similar presentations
Volume 61, Issue 2, Pages (August 2014)
Advertisements

Optimization of pre-ESRD care: The key to improved dialysis outcomes
Continued Smoking Exacerbates but Cessation Ameliorates Progression of Early Type 2 Diabetic Nephropathy  Kantima Phisitkul, MD, Khaled Hegazy, MD, Temduang.
Chronic Kidney Disease in Diabetes
Volume 54, Issue 2, Pages (August 1998)
Nutrition and chronic kidney disease
Reducing the Dietary Acid Load: How a More Alkaline Diet Benefits Patients With Chronic Kidney Disease  Caroline Passey, BSc, RD, PhD  Journal of Renal.
Volume 67, Pages S1-S7 (June 2005)
Differential Estimation of CKD Using Creatinine- Versus Cystatin C–Based Estimating Equations by Category of Body Mass Index  Suma Vupputuri, PhD, Caroline.
Chapter 3.1: Diagnosis of CKD–MBD: biochemical abnormalities
Frederik Persson, Peter Rossing  Kidney International Supplements 
Volume 83, Issue 3, Pages (March 2013)
Volume 56, Pages S54-S56 (July 1999)
Chapter 3.1: Diagnosis of CKD–MBD: biochemical abnormalities
Volume 79, Issue 12, Pages (June 2011)
Volume 92, Issue 4, Pages (October 2017)
Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States  Austin G. Stack, Bhamidipati V.R.
Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets  David M. Spiegel, Kate Brady  Kidney.
Volume 80, Issue 10, Pages (November 2011)
Corrections to "Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated.
John P. Middleton, Patrick H. Pun  Kidney International 
GFR Estimation: From Physiology to Public Health
Inflammation and wasting in chronic kidney disease: Partners in crime
Volume 80, Issue 2, Pages (July 2011)
I. Introduction American Journal of Kidney Diseases
Haiyan Wang, Luxia Zhang, Jicheng Lv  Kidney International 
Yasuhiro Hamada, Masafumi Fukagawa  Kidney International 
Erratum American Journal of Kidney Diseases
Volume 79, Pages S9-S13 (April 2011)
Volume 77, Issue 8, Pages (April 2010)
The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli  Richard J. Glassock, Andrew D. Rule  Kidney.
Volume 76, Pages S50-S99 (August 2009)
Reducing the Dietary Acid Load: How a More Alkaline Diet Benefits Patients With Chronic Kidney Disease  Caroline Passey, BSc, RD, PhD  Journal of Renal.
How to interpret the eGFR in patients with small body surface area
D. Batlle, P. Ramadugu, M.J. Soler  Kidney International 
Nutrition and chronic kidney disease
Volume 80, Issue 2, Pages (July 2011)
Renal risk scores: Progress and prospects
Clinical relevance of FGF-23 in chronic kidney disease
Acute myocardial infarction in patients with end-stage renal disease
Volume 65, Issue 2, Pages (February 2004)
Volume 86, Issue 3, Pages (September 2014)
Aggressive blood pressure reduction and renin–angiotensin system blockade in chronic kidney disease: time for re-evaluation?  Pantelis A. Sarafidis, Luis.
Volume 72, Issue 12, Pages (December 2007)
American Journal of Kidney Diseases
Volume 76, Issue 3, Pages (August 2009)
Methods for guideline development
Volume 76, Issue 1, Pages (July 2009)
Volume 76, Issue 8, Pages (October 2009)
Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD 
Volume 84, Issue 4, Pages (October 2013)
Arjang Djamali, Christina Kendziorski, Peter C. Brazy, Bryan N. Becker 
Volume 65, Issue 3, Pages (March 2004)
Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita  Kidney International 
Volume 80, Issue 12, Pages (December 2011)
Volume 76, Issue 7, Pages (October 2009)
Volume 81, Issue 1, Pages 7-9 (January 2012)
ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: The African American Study of Kidney Disease and Hypertension (AASK) trial 
Volume 86, Issue 6, Pages (December 2014)
Volume 80, Issue 10, Pages (November 2011)
Michael R. Lattanzio, Matthew R. Weir  Kidney International 
Charles A. Herzog  Kidney International 
Adiponectin: good, bad, or just plain ugly?
The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?  Richard E. Gilbert, Mark E. Cooper  Kidney.
Friends, social networks, and progressive chronic kidney disease
Kidney and hypertension
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Volume 57, Pages S44-S48 (April 2000)
Volume 74, Pages S4-S9 (December 2008)
Volume 86, Issue 2, Pages (August 2014)
Presentation transcript:

Volume 76, Pages S3-S11 (December 2009) Role of oxidants/inflammation in declining renal function in chronic kidney disease and normal aging  Helen Vlassara, Massimo Torreggiani, James B. Post, Feng Zheng, Jaime Uribarri, Gary E. Striker  Kidney International  Volume 76, Pages S3-S11 (December 2009) DOI: 10.1038/ki.2009.401 Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 1 Survival curves in patients stratified by measured or estimated creatinine clearance. Upper panels reprinted from Pizzarelli et al.9 by permission of Oxford University Press on behalf of the European Renal Association-European Dialysis and Transplant Association. CrCl, creatinine clearance; MDRD, Modification of Diet in Renal Disease equation. Kidney International 2009 76, S3-S11DOI: (10.1038/ki.2009.401) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 2 Key opposing roles of two major AGE receptors. AGE, advanced glycation end product; AGER1, AGE receptor-1; RAGE, receptor for AGE. Kidney International 2009 76, S3-S11DOI: (10.1038/ki.2009.401) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 3 Age-related changes in serum AGE levels and renal function in a cohort of normal subjects. (a and b) Serum levels of CML and MG correlate with age. (c) Serum CML levels inversely correlate with the estimated glomerular filtration rate in the overall study cohort. (c, inset) A subgroup exists within the study cohort who do not show an age-related renal decline. CML, carboxymethyllysine; eGFRCr, estimated glomerular filtration rate using creatinine; MG, methylglyoxal. Reprinted with permission of the American Society of Nephrology from Vlassara et al., Chapter 7, Online Geriatric Nephrology Curriculum, 2009 (http://www.asn-online.org/education_and_meetings/geriatrics). Kidney International 2009 76, S3-S11DOI: (10.1038/ki.2009.401) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 4 Effects of AGEs on inflammation in healthy subjects. (a) Serum AGEs correlate with plasma lipid peroxidation products (8-isoprostanes) in nondiabetic subjects. (b) Levels of hsCRP and TNF-α are elevated in healthy subjects consuming AGE-rich diets (>23 Eq/day) but not in those consuming a low-AGE diet (<15.4 Eq/day). Note that the high-AGE group had a body mass index >33. *P=0.025. AGE, advanced glycation end product; hsCRP, high-sensitivity C-reactive protein; sAGE, serum AGE; TNF-α, tumor necrosis factor-α. Reprinted with permission of the American Society of Nephrology from Vlassara et al., Chapter 7, Online Geriatric Nephrology Curriculum, 2009 (http://www.asn-online.org/education_and_meetings/geriatrics). Kidney International 2009 76, S3-S11DOI: (10.1038/ki.2009.401) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 5 Alterations in markers of oxidant stress and inflammation resulting from reducing the amounts of AGEs in the diet of normal subjects and CKD patients. In both groups (a and b), subjects continued their normal diet but prepared their food using cooking methods specifically designed to reduce dietary AGE content by ∼50%. AGE, advanced glycation end product; AGER1, AGE receptor-1; CKD, chronic kidney disease; 8-iso, 8-isoprostane; RAGE, receptor for AGE; sCML, serum carboxymethyllysine. Kidney International 2009 76, S3-S11DOI: (10.1038/ki.2009.401) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 6 Serum and urine AGE kinetics in normal or diabetic subjects. (a) Normal adults were fed a regular (i.e., high-AGE, solid lines) meal or a meal with 50% lower AGEs (i.e., low-AGE, dashed lines). (b) Diabetic patients with very little (dashed lines) or mild nephropathy (solid lines) were fed the regular (i.e., high-AGE) meal. Compared with normal subjects, the diabetic group with a lower glomerular filtration rate had higher baseline and more prolonged elevation of serum AGE levels, corresponding to significantly reduce urine AGE levels. Note that although neither diabetic group had severe disease, both had markedly lower AGE excretion than normal subjects. AGE, advanced glycation end product; μ/alb, microalbuminuria; CCr, creatinine clearance. Reprinted with permission of the American Society of Nephrology from Vlassara et al., Chapter 7, Online Geriatric Nephrology Curriculum, 2009 (http://www.asn-online.org/education_and_meetings/geriatrics). Kidney International 2009 76, S3-S11DOI: (10.1038/ki.2009.401) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 7 Cardiac and renal fibrosis as a direct result of the amount of AGEs in the diet. Kidney (a–c) and cardiac (d–f) histology in healthy mice fed an ad-lib (high-AGE), a calorie-restricted (40–50% reduction), or an MG-supplemented calorie-restricted diet. Kidney and heart lesions were less severe in calorie-restricted mice than in those fed either the ad-lib diet or the calorie-restricted diet supplemented with MG. AGE, advanced glycation end product; CR, calorie restricted; MG, methylglyoxal. Original magnification × 250. Reprinted from Cai et al.12 with permission from the American Society for Investigative Pathology. Kidney International 2009 76, S3-S11DOI: (10.1038/ki.2009.401) Copyright © 2009 International Society of Nephrology Terms and Conditions